abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Report

7 Mar 2019

Author:
Equileap

USA: Report assesses 100 leading companies on workplace equality incl. healthcare benefits

"Gender equality in the US: Assessing 100 leading companies on workplace equality including healthcare benefits", Feb 2019

This Special Report comes against a back-ground of rapid change in the past two years in the United States in attitudes towards gen-der equality in the workplace, with a number of brave voices speaking out, many of them through the #metoo and Time's Up movements...

...The aim of the research is to assess the performance of 100 of the largest US compa-nies on gender equality, including an evalua-tion of the healthcare benefits they provide, es-pecially the quality of maternal healthcare and family planning...

...There is now a patchwork of availability, leaving many women in the US unable to access health care without extra costs and delay. This means that the type and quality of health plans employers choose to offer, is an important part of evaluating US companies on gender equality in the workplace...

This report provides an analysis of how the companies in the S&P 100 index perform on the Equileap Gender Equality Scorecard™, followed by our findings regarding their healthcare be-nefits. Lastly we have provided a combined ranking on gender equality and access to healthcare. The analysis is based on data our research team was able to collect from publicly available information or completed question-naires. We end with a number of conclusions, one of the most important being that there is limited transparency in the US corporate sec-tor regarding access to healthcare, and repro-ductive care in particular...